NEUE CXC-CHEMOKIN-ANTAGONISTEN

Patent europeic · EP1943272 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1943272
Numer da la dumonda
EP06807665
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-10-2006
Publitgà
16-07-2008
Concedì
14-12-2011
Stritgà
31-10-2012
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/435 (2006.01)
C07K 16/18 (2006.01)
C12N 15/11 (2006.01)
C12N 15/12 (2006.01)
C12N 15/63 (2006.01)
C12N 15/90 (2006.01)
C12Q 1/68 (2006.01)
G01N 33/50 (2006.01)
G01N 33/53 (2006.01)
Prioritad
EP 05110205 31.10.2005
US 733547 P 04.11.2005
Dumonda PCT
PCT/EP2006/067939 30.10.2006
Publicaziun PCT
WO2007/051781 10.05.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-05-2013

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.05.2013

  2. 14-12-2011

    Concedì

    Published in Swissreg on 14.12.2011

  3. 14-12-2011

    Represchentant inscrit

    Representative
    Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva

    Published in Swissreg on 14.12.2011

Partidas

Possessur

Merck Serono SA

Centre Industriel, 1267 Coinsins, Vaud

Represchentant

Merck Serono S.A. - Geneva

IP Department 9, chemin des Mines, 1202 Geneva

Inventur

PROUDFOOT, Amanda

F-74140 Chens Sur Leman, FR

POWER, Christine

F-01710 Thoiry, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.